Issues in pharmaceutical price management MCQs With Answer explores core challenges in drug pricing, regulation and market access relevant to B.Pharm students. This introduction covers pricing strategies, regulatory frameworks (DPCO, NPPA), cost-plus vs value-based pricing, reference pricing, mark-ups across supply chains, pharmacoeconomics, reimbursement, affordability, and ethical concerns in price setting. Understanding price controls, tendering, generic pricing, parallel imports, and price transparency is essential for pharmacists involved in policy, procurement, or industry roles. These focused MCQs with answers emphasize practical scenarios, legal statutes, and calculation-based problems to strengthen your competency in pharmaceutical price management. Now let’s test your knowledge with 30 MCQs on this topic.
Q1. What is the primary objective of drug price regulation by authorities like NPPA or DPCO?
- Maximize pharmaceutical company profits
- Ensure affordable access to essential medicines
- Eliminate all private sector involvement
- Promote only imported medicines
Correct Answer: Ensure affordable access to essential medicines
Q2. Which pricing method sets price by adding a fixed percentage to the cost of production?
- Value-based pricing
- Cost-plus pricing
- Reference pricing
- Penetration pricing
Correct Answer: Cost-plus pricing
Q3. What is external reference pricing?
- Setting price based on therapeutic value within a country
- Benchmarking a drug’s price against prices in other countries
- Negotiating prices with individual patients
- Using production cost only to determine price
Correct Answer: Benchmarking a drug’s price against prices in other countries
Q4. Which term describes the maximum retail price printed on medicine packaging in India?
- Wholesale price
- Net selling price
- MRP (Maximum Retail Price)
- Ex-factory price
Correct Answer: MRP (Maximum Retail Price)
Q5. Value-based pricing primarily relies on which factor?
- Manufacturing cost
- Perceived patient and payer benefit
- Retailer commissions
- Import tariffs
Correct Answer: Perceived patient and payer benefit
Q6. Which pricing strategy aims to set a low initial price to gain market share?
- Skimming pricing
- Penetration pricing
- Cost-plus pricing
- Reference pricing
Correct Answer: Penetration pricing
Q7. In tender procurement, which factor most lowers the final procurement price?
- Single-source procurement
- Competitive bidding among suppliers
- High import duties
- Limited shelf life
Correct Answer: Competitive bidding among suppliers
Q8. Which is a common consequence of strict price controls on pharmaceuticals?
- Unlimited R&D investment
- Potential reduction in new drug launches
- Increased advertising expenditure
- Higher retail mark-ups
Correct Answer: Potential reduction in new drug launches
Q9. What does pharmacoeconomics evaluate in price management?
- Only the manufacturing process
- Cost-effectiveness and value of interventions
- Retail space optimization
- Pharmacist salaries
Correct Answer: Cost-effectiveness and value of interventions
Q10. Which pricing element is directly affected by VAT/GST?
- Therapeutic efficacy
- Final consumer price
- Clinical trial outcomes
- Drug stability
Correct Answer: Final consumer price
Q11. What is parallel import in pharmaceutical markets?
- Importing active pharmaceutical ingredients (APIs) only
- Importing a patented drug without consent from lower-priced markets
- Exporting domestic generics
- Importing packaging materials
Correct Answer: Importing a patented drug without consent from lower-priced markets
Q12. Which actor typically takes the largest percentage margin in the supply chain markup model?
- Manufacturer
- Wholesaler
- Retail pharmacist
- Payer
Correct Answer: Retail pharmacist
Q13. Reference price systems are intended to do which of the following?
- Ignore clinical equivalence
- Encourage price competition among therapeutically similar drugs
- Guarantee higher profits for brands
- Mandate single supplier contracts
Correct Answer: Encourage price competition among therapeutically similar drugs
Q14. What is a main ethical issue in pharmaceutical pricing?
- Ensuring exclusive patent monopolies forever
- Balancing profit motives with patient affordability
- Limiting prescribing to specialists
- Mandatory advertising of high prices
Correct Answer: Balancing profit motives with patient affordability
Q15. Which policy tool can governments use to control prices of essential medicines?
- Price gouging laws only
- Price ceilings and scheduled price lists
- Prohibiting generic manufacturing
- Eliminating public procurement
Correct Answer: Price ceilings and scheduled price lists
Q16. In cost-effectiveness analysis, what does ICER stand for?
- International Cost Evaluation Ratio
- Incremental Cost-Effectiveness Ratio
- Integrated Clinical Efficacy Result
- Internal Cost Efficiency Review
Correct Answer: Incremental Cost-Effectiveness Ratio
Q17. Price discrimination in pharma may lead to:
- Same price for all countries
- Different prices for different payers or countries
- Uniform quality of production
- One-time pricing only
Correct Answer: Different prices for different payers or countries
Q18. Which factor is least likely considered in value-based pricing?
- Patient outcomes
- Comparator treatment benefits
- Production line capacity
- Healthcare cost offsets
Correct Answer: Production line capacity
Q19. What is the effect of generic substitution on drug prices?
- It generally increases prices
- It often reduces prices through competition
- It removes all quality control
- It favors only branded products
Correct Answer: It often reduces prices through competition
Q20. Which document often lists ceiling prices for scheduled formulations in India?
- Clinical trial registry
- Drug Price Control Order (DPCO)
- Pharmacy practice guidelines
- Marketing authorization certificate
Correct Answer: Drug Price Control Order (DPCO)
Q21. What is the primary role of a national drug pricing authority?
- R&D funding allocation
- Setting, monitoring and enforcing drug prices
- Manufacturing drugs
- Approving clinical trial protocols
Correct Answer: Setting, monitoring and enforcing drug prices
Q22. Which pricing approach might include rebates, discounts or managed entry agreements?
- List price only
- Managed or confidential pricing arrangements
- Pure cost-plus with no variation
- Retail fixed price law
Correct Answer: Managed or confidential pricing arrangements
Q23. Price transparency in pharmaceutical supply chains aims to:
- Hide discounts from payers
- Improve accountability and fair pricing
- Eliminate competition
- Increase black market sales
Correct Answer: Improve accountability and fair pricing
Q24. Which of these increases the effective cost to patients despite a low ex-factory price?
- High distribution and retail mark-ups
- Low R&D expenditure
- Good manufacturing practices
- Strong patent protection
Correct Answer: High distribution and retail mark-ups
Q25. Tendering for public procurement often favors which product attribute besides price?
- Therapeutic equivalence and quality assurance
- Number of advertisements
- Higher MRP
- Celebrity endorsements
Correct Answer: Therapeutic equivalence and quality assurance
Q26. Which measure helps ensure affordability for chronic medications?
- Short-term promotional pricing
- Chronic disease reimbursement and price controls
- Exclusive brand monopolies
- Reduced pharmacist training
Correct Answer: Chronic disease reimbursement and price controls
Q27. Which is a risk when manufacturers offer steep introductory discounts?
- Long-term sustainable pricing
- Potential price erosion and unsustainable margins
- Increased patent duration
- Guaranteed market exclusivity
Correct Answer: Potential price erosion and unsustainable margins
Q28. What is ‘markup’ in the context of pharmaceutical retail?
- Quality certification process
- Difference between purchase price and selling price
- Clinical efficacy percentage
- Regulatory approval timeline
Correct Answer: Difference between purchase price and selling price
Q29. Which indicator measures how sensitive demand is to price changes?
- Price elasticity of demand
- Gross domestic product
- Therapeutic index
- Bioavailability coefficient
Correct Answer: Price elasticity of demand
Q30. Which approach helps balance innovation incentives and access to medicines?
- Perpetual patents with no regulation
- Tiered pricing, compulsory licensing and public funding
- Eliminating generics entirely
- Banning international price comparisons
Correct Answer: Tiered pricing, compulsory licensing and public funding
